| Literature DB >> 31497020 |
Tanushree Mukherjee1, Kithiganahalli Narayanaswamy Balaji1.
Abstract
A large proportion of the world is inflicted with health concerns arising from infectious diseases. Moreover, there is a widespread emergence of antibiotic resistance among major infectious agents, partially stemming from their continuous dialog with the host, and their enormous capacity to remodel the latter toward a secure niche. Among the several infection-driven events, moderation of WNT signaling pathway has been identified to be strategically tuned during infections to govern host-pathogen interactions. Primarily known for its role in arbitrating early embryonic developmental events; aberrant activation of the WNT pathway has also been associated with immunological consequences during diverse patho-physiological conditions. Here, we review the different mechanisms by which components of WNT signaling pathways are exploited by discrete bacterial agents for their pathogenesis. Furthermore, recent advances on the cross-talk of WNT with other signaling pathways, the varied modes of WNT-mediated alteration of gene expression, and WNT-dependent post-transcriptional and post-translational regulation of the immune landscape during distinct bacterial infections would be highlighted.Entities:
Keywords: Wnt; epigenetics; infectious diseases; nuclear Wnt signaling; therapeutics
Mesh:
Year: 2019 PMID: 31497020 PMCID: PMC6712069 DOI: 10.3389/fimmu.2019.01985
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1An overview of Wnt signaling pathway.
Interactions of bacterial pathogens with Wnt pathway components.
| Canonical β-CATENIN pathway | Maintaining inflammatory equipoise through the regulation of IDO1 | ( | |
| R-spondin 2-mediated Wnt activation | Involved in loss of intestinal differentiation | ( | |
| Leads to increased MHC-II responses and Th1/17-driven hyper-inflammation | ( | ||
| Wnt3a | Induction of apoptosis | ( | |
| Wnt3a | Inhibition of necrosis | ( | |
| Wnt2 | Inhibition of necrosis | ( | |
| BCG, | Wnt5a, Fzd4, Lrp5 | Inhibition of autophagy | ( |
| Canonical Wnt/Dvl-mTOR axis | Inhibition of autophagy | ( | |
| Downregulation of Wnt5a | Inhibition of autophagy | ( | |
| Wnt6, Wnt10a, Fzd5, Fzd9, Lrp6, Tcf7 | Assist bacterial internalization and survival | ( | |
| Wnt11 | Inhibition of | ( | |
| Fzd1 | Production of anti-inflammatory cytokines IL-10, TGFβ | ( | |
| Wnt5a-Fzd5 | Induction of pro-inflammatory immune response | ( | |
| Wnt6 | Expressed in lipid droplets and associated with production of anti-inflammatory Arginase1 | ( | |
| Wnt5a, Fzd4, Lrp5 | Regulatory T cell expansion | ( | |
| Downregulated Wnt signaling (cytosolic β-CATENIN) | Inhibition of goblet cell maturation at peak of infection | ( | |
| Upregulation of negative regulators of Wnt pathway - RNF43 ZNRF3 | Intestinal stem cell renewal and differentiation, thereby preventing intestinal infections | ( | |
| Fzd1, 2, 7 | Assist in pathogen internalization | ( | |
| Axin1 | Limits invasion into host cells | ( | |
| Epigenetic downregulation of WIF1, leading to Wnt activation | Crypt hyperplasia and tumorigenesis | ( |
Figure 2The unexplored facets of Wnt signaling during bacterial infections.